Thursday, November 15, 2012
Print Current Day:
|
|
SESSION 11 SCHEDULE | |
Thursday
SESSION 11:
LOWER EXTREMITY HOT TOPICS I (5-MINUTE TALKS)
Moderators:Enrico Ascher, MD / Bruce J. Brener, MD
|
|
x | |
6:35 AM - 6:40 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
6:40 AM - 6:45 AM | DEBATE: 2-3 Year Comparison Of Sirolimus Eluting Stents (SESs) vs. Bare Metal Stents (BMSs) For Below-Knee And Tibial Occlusive Disease (YUKON Trial) |
Presenter(s):Gunnar Tepe, MD | |
6:46 AM - 6:51 AM | DEBATE: Drug Eluting Balloons (DEBs) Are Better For Below-Knee Lesions Than SESs: 1-Year Results |
Presenter(s):Francesco Liistro, MD | |
6:52 AM - 6:57 AM | Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices |
Presenter(s):Koen Deloose, MD / Marc Bosiers, MD | |
View Abstract | |
6:58 AM - 7:03 AM | New Developments In Distal Puncture Techniques For Treating CTOs Of Lower Extremity Arteries: The Funnel Balloon Catheter; 3 Fr Sheath; Needle Extensions And COR Balloons |
Presenter(s):Andrej Schmidt, MD | |
7:04 AM - 7:09 AM | Best Treatment Of Popliteal Lesions: Stent vs. PTA: The ETAP Trial |
Presenter(s):Thomas Zeller, MD | |
7:10 AM - 7:15 AM | Value Of The Biodegradable Balloon Expandable Remedy Stent For Lower Extremity Lesions: The GAIA Trial Results |
Presenter(s):Dierk Scheinert, MD | |
7:16 AM - 7:21 AM | Does Atherectomy Help To Treat Resistant Calcified SFA Lesions: Does It Require A Distal Filter For Safety |
Presenter(s):Daniel G. Clair, MD | |
7:22 AM - 7:27 AM | DEBATE: Current Role Of New Atherectomy Devices: They Work And Justify The Costs |
Presenter(s):James F. McKinsey, MD | |
7:28 AM - 7:33 AM | DEBATE: Debulking With Atherectomy And Laser Is A Good Idea Whose Time Has Passed |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
7:34 AM - 7:40 AM | Panel Discussion |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Thursday
SESSION 12:
LOWER EXTREMITY HOT TOPICS II (5-MINUTE TALKS)
Moderators:Kenneth Ouriel, MD, MBA, FACS, FACC / Evan C. Lipsitz, MD
|
|
x | |
7:40 AM - 7:45 AM | Long-Term Evaluation (To 5 Years) Of SFA Stents In 1000 Patients: Importance Of TASC Classification, Stent Type And Lesion Length (Belgian/German Study) |
Presenter(s):Marc Bosiers, MD / Giovanni Torsello, MD / Patrick Peeters, MD | |
7:46 AM - 7:51 AM | The Many Uses And Advantages Of The Supera Veritas Stent (IDEV) To Treat Femoropopliteal Lesions |
Presenter(s):Peter C.J. Goverde, MD / Dierk Scheinert, MD | |
7:52 AM - 7:57 AM | 1-Year Results Of The Protege Everflex Stent (ev3) To Treat Popliteal Lesions: DURABILITY-POP Study |
Presenter(s):Patrick Peeters, MD | |
7:58 AM - 8:03 AM | DEBATE: CFA And DFA Occlusive Lesions Are Best Treated By Endovascular Techniques |
Presenter(s):Thomas Zeller, MD | |
8:04 AM - 8:09 AM | DEBATE: How Should CFA And DFA Occlusive Lesions Best Be Treated |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
8:10 AM - 8:15 AM | Extreme Approaches To CTOs via Retrograde Puncture Of Pedal Loop And Digital Arteries: How To Do It |
Presenter(s):Marco G. Manzi, MD | |
8:16 AM - 8:21 AM | DEBATE: Stenting Is Still First Line Treatment For SFA Occlusive Disease |
Presenter(s):Erich Minar, MD | |
8:22 AM - 8:27 AM | DEBATE: Why Should Metal Be Avoided In The SFA And How To Do It |
Presenter(s):Giancarlo Biamino, MD, PhD | |
8:28 AM - 8:33 AM | How To Remove Small Procedural Emboli From Tibial Arteries |
Presenter(s):Andrej Schmidt, MD | |
8:34 AM - 8:39 AM | What To Do For CLI Patients When There Are No Patent Outflow Arteries: Can DEBs Help |
Presenter(s):Roberto Ferraresi, MD | |
8:40 AM - 8:46 AM | Panel Discussion |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Thursday
SESSION 13:
LOWER EXTREMITY HOT TOPICS III (5-MINUTE TALKS)
Moderators:Jacques Busquet, MD / Luis A. Sanchez, MD
|
|
x | |
8:46 AM - 8:51 AM | DEBATE: Atherectomy And DEBs For Native Disease And In Stent Restenosis In The SFA And Popliteal: Stents Can Be Avoided Completely |
Presenter(s):Thomas Zeller, MD | |
8:52 AM - 8:57 AM | DEBATE: DEBs Won’t Do The Job Alone: Stents Will Be Needed Sometimes For Recoil Or Dissection |
Presenter(s):Dierk Scheinert, MD | |
8:58 AM - 9:03 AM | The Tack-It Device: An Endovascular Stapler For Imperfect PTAs To Avoid Stenting |
Presenter(s):Peter A. Schneider, MD | |
9:04 AM - 9:09 AM | 3-Year Results Of The RESILIENT Trial With The Lifestent: Are The Results Of SFA Stents Durable |
Presenter(s):John R. Laird, MD | |
9:10 AM - 9:15 AM | 3-Year Results From The ZILVER PTX Drug Eluting Stent (DES) Trial: Are The Results Durable And How Do Patterns Of Restenosis Differ |
Presenter(s):Michael D. Dake, MD / Gary M. Ansel, MD | |
9:16 AM - 9:21 AM | 2-Year Outcomes Of Stent Supported PTA For Iliac Lesions: Balloon vs. Self-Expanding Stents: Influence Of TASC Classification: The BRAVISSIMO Trial |
Presenter(s):Patrick Peeters, MD | |
9:22 AM - 9:27 AM | DEBATE: To Treat Lower Extremity Chronic Total Occlusions (CTOs) One Only Needs A Wire And A Catheter And Not All This Expensive Nonsense |
Presenter(s):Amman Bolia, MD | |
9:28 AM - 9:33 AM | DEBATE: We Need All This Stuff And More To Meet Unmet Needs With Lower Extremity Occlusive Disease |
Presenter(s):Gary M. Ansel, MD | |
9:34 AM - 9:39 AM | How To Use A Radiofrequency Wire To Cross Difficult CTOs: Advantages, Precautions, Limitations |
Presenter(s):Marcelo S. Guimaraes, MD | |
9:40 AM - 9:45 AM | ALL CLI Is Not The Same: This And Diabetic Status Render Limb Salvage Rates A Poor Index Of Success With Revascularization Procedures: Some Limbs With CLI Survive With Conservative Treatment And Prayer |
Presenter(s):Francesco Serino, MD | |
9:46 AM - 9:54 AM | Panel Discussion Conclusion of Joint Sessions with VEITHsymposium. VEITHsymposium continues after the Break in the Grand Ballroom, 3rd Floor. AIMsymposium continues at 10:00 a.m. |
9:54 AM - 10:10 AM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
Thursday
SESSION 14:
WHAT’S NEW IN EMBOLIZATION OF BENIGN AND MALIGNANT DISEASE - PART 1
Moderators:Curtis W. Bakal, MD, MPH / Jos C. van den Berg, MD, PhD
|
|
x | |
10:00 AM - 10:10 AM | Evaluation And Management Of Prostatic Hypertrophy |
Presenter(s):Lloyd S. Minsky, MD | |
10:10 AM - 10:20 AM | Prostatic Embolization For BPH: Is It Ready For Prime Time? |
Presenter(s):Tiago Bilhim, MD, PhD, EBIR | |
View Abstract | |
10:20 AM - 10:30 AM | Single Center Results For BPH Embolization: Is It Worth The Risks? |
Presenter(s):Francisco C. Carnevale, MD, PhD | |
10:30 AM - 10:40 AM | Prostate Embolization: Technical Tips Based On Our Early Experience |
Presenter(s):Jafar Golzarian, MD | |
10:40 AM - 10:50 AM | UFE: Are There Any True Contraindications? |
Presenter(s):David N. Siegel, MD | |
10:50 AM - 11:00 AM | Managing Complications Of UFE |
Presenter(s):Richard D. Shlansky-Goldberg, MD | |
11:00 AM - 11:10 AM | CO2 Angiography Can Significantly Decrease Contrast Use In The IR Suite |
Presenter(s):James Caridi, MD | |
11:10 AM - 11:20 AM | Preplanning IR Procedures Will Reduce Radiation Exposure To Both Patients And Operators |
Presenter(s):Gabriel Bartal, MD, FSIR, FCIRSE | |
View Abstract | |
11:20 AM - 11:30 AM | Managing Patients With HCC: What The Interventional Radiologist Needs To Know |
Presenter(s):Paul J. Gaglio, MD | |
View Abstract | |
11:30 AM - 11:40 AM | TACE Or Ablation: Which Is Best Or Is There A Role For Both? |
Presenter(s):Daniel B. Brown, MD | |
11:40 AM - 11:50 PM | DEB TACE Has Surpassed Conventional TACE: Where Is The Evidence? |
Presenter(s):Jean Francois H. Geschwind, MD | |
11:50 AM - 12:00 PM | Radioembolization (Y90) For The Treatment Of HCC |
Presenter(s):Matthew S. Johnson, MD | |
View Abstract | |
12:00 PM - 12:50 PM | Lunch Break (Americas Hall I – 3rd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
Thursday
SESSION 15:
WHAT’S NEW IN EMBOLIZATION OF BENIGN AND MALIGNANT DISEASE - PART 2
Moderators:Curtis W. Bakal, MD, MPH / Jos C. van den Berg, MD, PhD
|
|
x | |
12:50 PM - 1:00 PM | Assessing The Response To Local Regional Therapy |
Presenter(s):Riccardo Lencioni, MD | |
1:00 PM - 1:05 PM | TACE In The Presence Of TIPS Or PV Thrombus |
Presenter(s):Jacob Cynamon, MD | |
1:05 PM - 1:15 PM | Neurovascular Tools In The Non-Neurovascular Arena |
Presenter(s):Richard R. Saxon, MD | |
1:15 PM - 1:30 PM | Panel Discussion |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
Thursday
SESSION 16:
INTERVENTIONAL RADIOLOGISTS’ ROLE IN THE MANAGEMENT OF METASTATIC DISEASE
Moderators:Andreas Kaubisch, MD / Jacob Cynamon, MD
|
|
x | |
1:30 PM - 1:40 PM | Colorectal Mets Management: An Overview |
Presenter(s):Andreas Kaubisch, MD | |
1:40 PM - 1:50 PM | When Is Surgical Resection Best? |
Presenter(s):Milan Kinkhabwala, MD | |
1:50 PM - 2:00 PM | Portal Vein Embolization: Indications, Tips And Tricks |
Presenter(s):David C. Madoff, MD | |
2:00 PM - 2:10 PM | Why Y90 Should Be The Treatment Of Choice For Most Metastatic Liver Lesions |
Presenter(s):Matthew S. Johnson, MD | |
2:10 PM - 2:20 PM | Tailored Radioembolization: Diffuse Liver vs. Lobectomy |
Presenter(s):Daniel Y. Sze, MD, PhD | |
2:20 PM - 2:30 PM | Technical Considerations For Optimizing Y90 Outcomes |
Presenter(s):Riad Salem, MD, MBA | |
2:30 PM - 2:40 PM | Role Of DEBIRI/Ablation: Current Role Of Combination Therapy In CRC Liver Mets |
Presenter(s):Riccardo Lencioni, MD | |
2:40 PM - 2:50 PM | Metastatic Disease: When Should You Use TACE, Y90 Or ChemoSaturation? |
Presenter(s):Daniel B. Brown, MD | |
2:50 PM - 3:00 PM | US Experience With ChemoSaturation |
Presenter(s):Krishna kandarpa, MD, PhD | |
3:00 PM - 3:10 PM | Initial European Institute of Oncology (EIO) Experience With Hepatic ChemoSaturation |
Presenter(s):Pier Francesco Ferrucci, MD, PhD | |
3:10 PM - 3:20 PM | Panel Discussion |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
x | |
3:20 PM - 3:30 PM | Microwave vs. RF vs. IRE: Is There A Clear Winner |
Presenter(s):Constantinos T. Sofocleous, MD, PhD | |
3:30 PM - 3:40 PM | Update On Clinical Trials Of Image Guided Ablations |
Presenter(s):Riccardo Lencioni, MD | |
3:40 PM - 3:50 PM | Lung Cancer: Limits Of Ablation |
Presenter(s):Constantinos T. Sofocleous, MD, PhD | |
3:50 PM - 4:00 PM | Renal Cancer: Indications For Percutaneous Ablation |
Presenter(s):William Alago, MD | |
4:00 PM - 4:10 PM | Image Guided Ablation: Navigation Tools You Should Be Familiar With |
Presenter(s):Joshua L. Weintraub, MD, FSIR | |
4:10 PM - 4:20 PM | Percutaneous Oncolytic Virus Therapy: Is It Feasible And Safe? |
Presenter(s):Steven C. Rose, MD | |
View Abstract | |
4:20 PM - 4:40 PM | Panel Discussion |
END OF SESSION 17 | |
SESSION 18 SCHEDULE | |
Thursday
SESSION 18:
PORTAL HYPERTENSION AND OTHER LIVER DIRECTED THERAPIES
Moderators:Jacob Cynamon, MD
|
|
x | |
4:40 PM - 4:50 PM | Portal HTN: Does The Data Suggest That Early TIPS For The Management Of Ascites Will Save Lives |
Presenter(s):Yosef Golowa, MD | |
4:50 PM - 5:00 PM | TIPS Should Be Done By All |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
5:00 PM - 5:10 PM | TIPS Should Only Be Done By Experts |
Presenter(s):Gary P. Siskin, MD | |
5:10 PM - 5:20 PM | Management Of Ascites With A Denver Shunt: What You Need To Know |
Presenter(s):George I. Getrajdman, MD | |
5:20 PM - 5:30 PM | Unusual Liver Abnormalities And Their Management |
Presenter(s):Ernest J. Ring, MD | |
5:30 PM - 5:40 PM | BRTO Has Definite Indications And Is Being Underutilized In The US |
Presenter(s):Yosef Golowa, MD | |
5:40 PM - 5:50 PM | Panel Discussion |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Thursday
SESSION 19:
NEW DEVELOPMENTS IN INTERVENTIONAL RADIOLOGY
Moderators:Jacob Cynamon, MD / Curtis W. Bakal, MD, MPH
|
|
x | |
5:50 PM - 6:00 PM | Thoracic Duct Embolization: A Technique That Is Easily Learned By Interventional Radiologists |
Presenter(s):Maxim Itkin, MD | |
6:00 PM - 6:10 PM | Is There A Role For IR In The Management Of Obesity |
Presenter(s):Gary P. Siskin, MD | |
END OF SESSION 19 |